Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ImmunoPrecise Antibodies Ltd. ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer June 27, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™ June 25, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology June 12, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery June 10, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR) June 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications March 28, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments March 20, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024* March 14, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology March 07, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 March 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* December 14, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Announces Closing of $1.265 Million Public Offering of Common Shares December 08, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Announces Pricing of $1.1 Million Public Offering of Common Shares December 06, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Announces Proposed Public Offering of Common Shares December 05, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call November 27, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research November 13, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™ October 25, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Provides Update on Growth Strategy and Recent Share Price Movement October 23, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Announces CFO Transition September 19, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 September 14, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023 September 08, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Announces Board Refreshment September 05, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Responds to 13D Filing August 09, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Antibodies Invites Investors and Stakeholders to Exclusive Interview with Market Radius Research July 14, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023 July 07, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023. June 29, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 March 16, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023 March 07, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 December 15, 2022 From IMMUNOPRECISE ANTIBODIES LTD. Via Business Wire Tickers IPA IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022 December 05, 2022 From ImmunoPrecise Antibodies Ltd. Via Business Wire Tickers IPA Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.